Brellium is an AI-powered clinical compliance platform based in New York City, founded in 2023 by Henry Kasa, Alex Le Tu, Max Katzman, and Zach Rosen. The company focuses on providing auditing and compliance solutions for a wide array of healthcare services, particularly for applied behavior analysis (ABA), behavioral health care, and substance use disorder centers. As of April 2025, Brellium has raised $16.7 million in Series A funding with participation from investors like First Round Capital and Left Lane.
Attribute | Information |
---|---|
Founding Date | 2023 |
Headquarters | New York City, United States |
Founders | Henry Kasa, Alex Le Tu, Max Katzman, Zach Rosen |
Revenue | Not publicly disclosed |
Profits | Not publicly disclosed |
Key Investors | First Round Capital, Menlo Ventures, Left Lane |
Industry | AI-powered Clinical Compliance |
Number of Employees | Not publicly specified |
Brellium started its journey in 2023 under the leadership of its four founders, each bringing a unique expertise in technology and healthcare solutions. The company quickly garnered attention for its innovative use of AI to automate and optimize medical chart reviews, enhancing compliance and accuracy in documentation. Its early focus was primarily on ABA services, but it soon expanded to aim its solutions at a broader range of healthcare practices. By leveraging AI, Brellium reduced processing times and increased the accuracy of compliance checks, setting a solid foundation for future growth.
Brellium's business model revolves around utilizing AI for efficient and reliable clinical compliance checks. The platform audits clinical documentation and billing notes, identifying discrepancies and improving documentation quality. Some major achievements include:
Brellium currently operates as a vital player in the AI-driven healthcare compliance sector. Its solutions are utilized by over 100,000 providers, ensuring every patient visit adheres to payor and clinical quality standards. Brellium holds a competitive edge due to its real-time audit capabilities and comprehensive coverage across sectors such as behavioral health, ABA therapy, and substance use disorder management. The company's expansion plans include scaling its offerings in telehealth and chronic care management.
Brellium continues to solidify its presence in the healthcare sector through technological advancements and strategic growth initiatives. The company's commitment to improving healthcare compliance through innovative AI solutions positions it as a leader in its field. Looking forward, Brellium has the potential to expand its reach globally, contributing significantly to enhancing healthcare quality and efficiency. The ongoing expansion in service offerings and funding acquisitions exemplifies Brellium's trajectory towards becoming an indispensable entity in healthcare solutions.